Pune, India -- (SBWire) -- 06/25/2018 --Segmentation: Global Topical Drug Delivery Market
Global Topical Drug Delivery Market, By Product Type (Topical Drug Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World)
Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-drug-delivery-market
Drivers: Global Topical Drug Delivery Market
Some of the major factors driving the topical drug delivery market are ability to deliver drug at the desired site, inter-and intra-patient variations, without fluctuations in drug levels, an enhanced suitability for self-medication and improved compliance. Also, increasing aging population, growing prevalence of skin related ailments and rising prevalence of chronic diseases, also new and better technologies for topical drug delivery is expected to boost the growth of this market are the major factors driving the growth of the injectable drug delivery market.
RISING CASES OF ACUTE AND CHRONIC DISEASES
The prevalence of diseases and conditions such as infections which includes bacterial infection and fungal infections, inflammations, pain management, acne, sun burns, psoriasis, dermatitis, skin allergy, skin cancer, diabetes, and many others has increased considerably over a period of time.
RISING AGING POPULATION
With the increasing age, the cases of acute and chronic diseases are rising. Older population is more prone to diseases such as diabetes, allergy, arthritis, infections, and dermatitis.
TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
With the rising prevalence of acute and chronic diseases it has become important for the drug and device manufacturers to develop advanced technologies that will provide more effective treatment for the diseases. In the few years, many developments took place for the topical drug delivery due to the rapid absorption of drugs.
APPROVAL OF NEW DRUGS
With the increasing demand for the treatment of diseases using painless and non-invasive method the demand for topical drug delivery is increasing.
BETTER OPPORTUNITY IN PHARMERGING MARKETS
According to DataBridge Market Research analysts, Japan, Europe and North America are expected to account for around 73% of total global pharmaceutical market, while the rest of the world only own 27% of the market.
Inquiry about this Report visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-drug-delivery-market
Major Players: Global Topical Drug Delivery Market
The major players in the topical drug delivery prescription drugs are Galderma Pharma, S.A., Allergen Plc. Kaken Pharmaceuticals, Co., Ltd, Pfizer, Bayer AG, 3M, Hisamitsu Pharmaceuticals, Co., Inc., Abbvie, Inc., Valeant Pharmaceuticals, Antares Pharma among others. Some of the other players in the global topical drug delivery market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., and Solvay among others.
Galderma Pharma S.A.
Galderma Pharma S.A. was incorporated in 1981, as a joint between Nestle and L'Oreal. In February, 2014 Nestle SA, entered into an agreement to acquire remaining 50% stake in the company, from L'Oreal S.A. After the completion of the acquisition the company will form the foundation of Nestle Skin Health S.A. Galderma Pharma S.A. is headquartered in Lausanne Switzerland.
Recent Developments:
In July 2016, Galderma announces fda approval of full prescription-strength differin gel for over-the-counter acne use.
In July 2016, Galderma announces approval of epiduo gel for the treatment of acne in Japan.
Bayer AG
Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science.
Recent Developments:
On July 2015, the U.S. Food and Drug Administration (FDA) approved Finacea Foam, for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
Valeant Pharmaceuticals International, Inc.
Founded in 1994 and headquartered in Quebec, Canada, Valeant Pharmaceuticals International, Inc. is a pharmaceutical company which engages in developing, manufacturing, and marketing pharmaceutical products in the areas of dermatology, eye health, neurology, and generics.
Recent Developments:
In August 2016, Valeant announced the re-launch of its generic of loxacin otic solution to treat bacterial ear infections. The product was temporarily discontinued in April 2015 due to an issue concerning the active pharmaceutical ingredient supplier, which has been resolved.
Read more about this Report visit @ http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market/
Table of Contents:
1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE
7. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
8. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER
10. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
11. GLOBAL TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
12. COMPANY PROFILES
13. RELATED REPORTS
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.
Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Global Topical Drug Delivery Market Worth 205.1 Billion USD by 2024 - Industry Research Analysis with Top Key Players Pfizer, Bayer AG, 3M, Hisamitsu Pharmaceuticals, Co., Inc., Abbvie, Inc
The global topical drug delivery market can be segregated into two kinds of products over the counter drugs and prescription drugs. Over the counter drugs are mainly focused on consumer care and the medical companies have no share in it. While the prescription drugs are having only 36.8% market share of the global topical drug delivery market, in 2018.